Strategic consultation
Pressure-test your U.S. / global development path.
Share non-confidential context about your oncology asset, indication, development stage, target geographies, and competitor concerns. We will respond to qualified inquiries about FIH site matching, competitor intelligence, and China-to-global strategy.
Direct emailcontact@oncolattice.bio
For qualified sponsor inquiries, we can discuss a scoped intelligence review using non-confidential asset, indication, mechanism, and target geography information.